March 26, 2020
10 min read
Keeping a Focus on Rare Disease During COVID-19
In this time of a viral pandemic, it is still important to keep a focus on rare diseases.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
April 28, 2025
8 min read
Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Blog
April 15, 2025
7 min read
Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
Blog
April 4, 2025
16 min read
Unlocking the Potential of Psychedelic Therapies
Psychedelic-assisted therapies are starting to emerge with potential as treatments for mental health conditions. Explore the evidence behind an increased interest in this use of substances such as psilocybin, MDMA, LSD, and DMT, and the future of research in this area.
Posts by Date
Blog
Blog
March 13, 2020
2 min read
ISPE’s Position on Real World Evidence (RWE)
Read more about the February 2020 position on RWE from ISPE.
Blog
February 25, 2020
5 min read
Lack of Label Alignment & Patient Safety Implications
Read the full article from UBC's pharmacovigilance team in Drugs Real World Outcomes.
Blog
February 4, 2020
6 min read
Future REMS Technology: Reduce Burden and Improve Safety
Learn more about UBC's presentation at the 12th REMS Summit.
Blog
December 19, 2019
1 min read
Risk Management Plan Development & Implementation
Listen to the full podcast from UBC with PharmaVOICE here.
Blog
November 21, 2019
4 min read
Top Trends in Oncology Patient Support
Find out what access and adherence challenges patients will need to overcome in the evolving oncology market.
Blog
October 3, 2019
3 min read
Are You Ready For Sentinel? | New RWE Safety Initiative
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Blog
September 3, 2019
3 min read
Immunogenicity: Meeting the Safety Reporting Requirements
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
Videos
July 17, 2019
1 min read
DIA 2019: Watch the Wrap-up of UBC’s Participation
See more of the developments UBC's evidence development and safety & risk management teams discussed.
Previous
